Yüklüyor......

Insulin Resistance in Pulmonary Arterial Hypertension, Is It a Novel Disease Modifier?

BACKGROUND: Recent studies have introduced glucose intolerance and insulin resistance (IR) as novel risk factors in patients with pulmonary arterial hypertension (PAH). OBJECTIVES: We aimed to investigate the prevalence of glucose intolerance and IR in patients with PAH and their correlation with fu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Res Cardiovasc Med
Asıl Yazarlar: Naderi, Nasim, Boobejame, Pedram, Bakhshandeh, Hooman, Amin, Ahmad, Taghavi, Sepideh, Maleki, Majid
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Kowsar 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4253803/
https://ncbi.nlm.nih.gov/pubmed/25478547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/cardiovascmed.19710
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!